CompanyHealthEnterprise
Tentarix Biotherapeutics
Tentarix Biotherapeutics is a San Diego biotech building conditionally active, multispecific biologics that switch on only at the cells where they are needed. Its proprietary stack - the VH-Select stabilized human VH scaffold, Tentacles multifunctional molecules, and the FunctionSeq mammalian-display screening engine - lets the company discover therapies with high cell selectivity and a wider therapeutic index across oncology, immuno-oncology, and autoimmune disease. Backed by Versant Ventures, Samsara BioCapital, Amplitude Ventures, and Gilead Sciences, and partnered with AbbVie and Gilead.
2020Founded
San DiegoHQ
$35 millionSeries B
biotechnologyconditional biologicsmultispecific antibodiesoncologyimmunologyautoimmune